Replies to post #215055 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Comments on twitter from Sean Sachdev, MD on Lomustine-temozolomide study.

I recall presented at SNO2017. Some issues: small numbers ~130 pts & imbalance; survival estimate comes from a stratified analysis & they used "inverse probability weights." With the pure unstratified analysis 31.4/37.9 (p=0.66) not statistically significant. Intriguing though.

https://pbs.twimg.com/media/DztPS9tWsAEqkqD.jpg

Sean Sachdev, MD @SeanSachdevMD
Radiation Oncologist, brain & spine, GU specialist. Assistant Professor at @NorthwesternMed @LurieCancer. #radonc #btsm #pcsm tweets = own opinion